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S108 Chronic Kidney Diseasedisease (CKD) with COPD. This population-based cohort study aimed to eval-
uate the all-cause mortality and major CV events of COPD among CKD pa-
tients using national health insurance (NHI) database in Taiwan.
Methods: CKD patients enrolled in the pre-end stage renal disease (pre-
ESRD) care management program, patients  40 years old who had at least
one outpatient diagnosis code (ICD-9 codes 585, 581.9) or at least one inpa-
tient diagnosis code and free of any dialysis or renal transplant from 1
January 2007 to 31 December 2011 were included. CKD patients with
COPD were matched to control subjects without COPD at a 1:1 ratio using
propensity scores. Cox proportional hazards regression models were used
to estimate hazard ratios (HRs) for all-cause mortality and major CV events
analysis.
Results: Propensity score matching yielded a cohort balanced on age, sex,
urbanization, socioeconomic status, enrolled year, comorbidities, Charl-
son Comorbidity Index score, clinical laboratory data, and medications
used, with 2498 CKD patients in the COPD group and 2498 in the non-
COPD group. CKD patients with COPD were associated with a higher risk
for death (HR, 1.134; 95% CI, 1.037e1.241) and non-significant risk for ma-
jor CV events (HR, 1.041; 95% CI, 0.905e1.198) compared to those without
COPD.
Conclusion: CKD patients with COPD are associated with higher all-cause
mortality and might increase risk of major CV events.http://dx.doi.org/10.1016/j.hkjn.2015.09.150
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Association Between Anemia and Abnormal Bleeding Times in Patients
with Chronic Kidney Disease
Ha Yeon Kim
Chonnam National University Medical School, Gwangju, Republic of Korea
Objective: Platelet dysfunction associated hemorrhagic complications and
chronic anemia are often encountered in patients with chronic kidney dis-
ease. The present study aimed to evaluate the association of anemia and
abnormal bleeding time in patients with chronic kidney disease.
Methods: We retrospectively analyzed the data of 1022 (60.24  15.89
years, men 58.7%). patients with chronic kidney disease.
Results: Patients with prolonged bleeding time (bleeding time > 182 sec)
were older age and lower eGFR, Hgb, Hct and PLT, and higher BUN and Cr
levels compared to those with normal bleeding time. The prevalence of
abnormal bleeding time was found to be higher as Hgb declined [25.0% for
patients with Hgb  10 mg/dl (n Z 595), 31.9% for patients with 8 
Hgb < 10 mg/dl (n Z 343), and 43.4% for patients with Hgb < 8 mg/dl
(n Z 84), P < 0.001, respectively]. eGFR was decreased as Hgb declined
(29.8  19.0 mL/min/1.73 m2 in patients with Hgb  10 mg/dl,
16.0  13.0 mL/min/1.73 m2 in patients with 8  Hgb < 10 mg/dl, and
10.3  8.61 mL/min/1.73 m2 in patients with Hgb < 8 mg/dl, P < 0.001,
respectively). Multivariate analysis revealed that age (OR, 1.019; 95% CI,
1.010e1.029), 8 mg/dl  Hgb < 10 mg/dl (OR, 1.214; 95% CI,
0.873e1.686), Hg < 8 mg/dl (OR, 1.820; 95% CI, 1.084e3.055), 15 mL/
min/1.73 m2  eGFR < 30 mL/min/1.73 m2 (OR, 1.616; 95% CI,
1.053e2.481), eGFR < 15 mL/min/1.73 m2 (OR, 1.668; 95% CI,
1.160e2.397), thrombocytopenia (PLT < 150  109/L) (OR, 2.659; 95% CI,
1.981e3.569) were independently associated with prolonged bleeding time.
Conclusion: Severe anemia (Hgb < 8 mg/dl) is independently associated
with prolonged bleeding time in chronic kidney disease, even after adjusting
for eGFR and other potential confounders.Fig.1 A. Multiple juxtra-articular masses near bilateral elbow joints,
wrist joints, metacarpophalangeal joints, interphalangeal joints, toe joints
and knee joints. B, C, D , E , F. X-ray manifestations: mass-like calcification
shadows in the peripheries of multiple joints all over the body; subcapital
fracture of right femur; linear calcification of middle and small arteries of
limbs, calcification of reticular vessels.http://dx.doi.org/10.1016/j.hkjn.2015.09.151
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Objective: This study assessed plasma cathelicidin, 25-OH vitamin D, and
natural killer (NK) cells which play an important role in innate immunity.
Methods: The study cohort included 175 patients who have a variety of esti-
mated glomerular filtration rate (eGFR) at the Chonnam National University
Hospital. Plasma catehlicidin level was measured by ELISA and absolutecount of NK cell was determined by flow cytometry. NK cell was identified
phenotypically as CD3-CD56+.
Results: The study population was divided into 3 groups according to the
eGFR: Group I, eGFR  60 mL/min/1.73 m2, n Z 33 (18.9%); group II, 15
 eGFR < 60 mL/min/1.73 m2, n Z 47 (26.8%); group III, eGFR < 15 mL/
min/1.73 m2, n Z 95 (54.3%), respectively. Plasma cathelicidin level was
decreased with lower eGFR (189.3  18.21 ng/ml in group I,
182.6  17.69 ng/ml in group II, and 179.7  17.76 ng/ml in group III,
P Z 0.032, respectively). On the other hand, percentages and absolute
numbers of NK cells were significantly higher in the peripheral blood of pa-
tients with lower eGFR (1897.7  1584.05 in group I, 2110.8  2168.37 in
group II, and 2833.8  2149.65 in group III, P Z 0.034, respectively). A
25-OH vitamin D was not distinguished in these groups, but after an exclu-
sion of pateints with hemodialysis, 25-OH vitamin D level showed
decreasing tendency with lower eGFR (16.4  6.22 ng/ml in group I,
12.4  4.74 ng/ml in group II, and 11.2  4.96 ng/ml in group III,
P Z 0.166, respectively).
Conclusion: Plasma cathelicidin level was significantly decreased with lower
eGFR while an absolute count of NK cells was increased with lower eGFR,
which might be associated with dysfunction of NK cells. After an exclusion
of patients with hemodialysis, 25-OH vitamin D concentration showed
decreasing tendency with lower eGFR.http://dx.doi.org/10.1016/j.hkjn.2015.09.152
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A 42-year-old male patient with uremia on hemodialysis was admitted due
to right foot ulcer and infection. Two years ago, he lost sight in the right
eye due to calcium salt deposition. One year ago, he developed multiple
peri-articular masses with progressive enlargement, which were identified
as hydroxyapatite. Acral gangrene occurred repeatedly throughout the
course of disease. Radiology indicated diffuse and continuous calcification
of middle and small arteries. Concomitant calcific uremic arteriolopathy
and hydroxyapatite crystal deposition disease were considered. The
diseases originated from abnormal disposition of hydroxyapatite in
conjunctiva, vessels and articular peripheries and shared a common
pathogenesis.
Fig.2 Ulcer of distal skin and blackening and gangrene of the 1st to the
4th toes in the right foot.
Fig.3 Contrast-enhanced X-ray manifestations: diffuse and continuous
pipestem or pipe-like calcification of middle and small arteries; marked ste-
nosis of part lumens. A large number of calcification foci could be found in
soft tissue around joints.
Fig.4 Multiple patchy and mass-like strong echoes adhering to the
capsule walls, with acoustic shadows accompanying behind, were found in
the cavities.
Fig.5 Calcium salt deposition and multinucleated giant cell aggregation
with granuloma reaction were found in pathological examination.
Fig.6 Near infrared spectrometer, composition: hydroxylapatite 70%,
proteins 20%, calcium oxalate monohydrate 10%.
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Successful Pregnancy and Labor for Women with Uremia: Report of 6
Cases with a Literature Review
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Zhejiang, China
Objective: The aim of this study was to summarize and analyze the clinical
manifestations for pregnant women with uremia.
Methods: Data on 6 pregnant female patients with uremia were retrospec-
tively analyzed with literature were reviewed.
Results: Five patients of pregnancy after renal transplantation were main-
tained on an immunosuppressive regimen before, during, and after the preg-
nancy, with none developing severe complication. Their offspring had
normal birth weight, postnatal growth and development. The function and
survival of renal allograft was not adversely affected by pregnancy. The
other one with uremia undergone hemodialysis experienced selective preg-
nancy terminated. Newborns delivered to the patient had low birth weight,
but no congenital defects were noted and development was normal.
Conclusion: The reasonable immunosuppressive regimen, prevention and
prompt therapy of complication, regular followed-up examination appears
to be crucial factors for a favourable pregnancy outcome for women with
uremia.http://dx.doi.org/10.1016/j.hkjn.2015.09.154
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Prevalence, Treatment, and Control of Hypertension in CKD Inpatients
of a Large Comprehensive Hospital in Eastern China: A Retrospective,
Single-center Survey
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Objective: This study aimed to assess the situation of prevalence, treatment
and control of hypertension in inpatients with chronic kidney disease.
Methods: This was a retrospective, single center study and cross-sectional
clinical epidemiology study.
Results: (1) 59.8% (438/733) inpatients were diagnosed with hypertension.
The average SBP of patients with hypertension was 142.03  20.98 mmHg
and 138.69  16.49 mmHg on admission and discharge, respectively
(p < 0.001). (2) 31.3% patients with hypertension were treated by one
type of antihypertensive drug, and this percentage was 36.5%, 22.8% and
9.6% in patients with two, three and four or more types of antihyperten-
sive drugs, respectively. 46.3% patients with hypertension used RASI.
CCB was used in 91.6% of patients with hypertension. (3) The percentage
of patients with BP < 140/90 mmHg was 49.3% on admission, and increased
to 53.2% when the patients were discharged (p < 0.001). On admission, the
percentages of patients with BP < 140/90 mmHg were 73.9%, 72.3%,
64.9%, 50.0% and 35.8% in patients with CKD1 to CKD5 stages, respectively.
But when the patients were discharged, these percentages were 78.3%,
76.9%, 70.1%, 46.7% and 39.9% in patients with CKD1 to CKD5 stages,
respectively.
